Loading...

PetMed Express

Nasdaq:PETS
Snowflake Description

Flawless balance sheet 6 star dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
PETS
Nasdaq
$352M
Market Cap
  1. Home
  2. US
  3. Retail
Company description

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The last earnings update was 18 days ago. More info.


Add to Portfolio Compare Print
  • PetMed Express has significant price volatility in the past 3 months.
PETS Share Price and Events
7 Day Returns
3.2%
NasdaqGS:PETS
3.1%
US Online Retail
0.5%
US Market
1 Year Returns
-59.9%
NasdaqGS:PETS
-6.3%
US Online Retail
0.8%
US Market
PETS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
PetMed Express (PETS) 3.2% -9.8% -16.9% -59.9% -3.5% 32.8%
US Online Retail 3.1% -3.1% 0.6% -6.3% 118.5% 220.1%
US Market 0.5% 0.2% 1.1% 0.8% 37.4% 37.5%
1 Year Return vs Industry and Market
  • PETS underperformed the Online Retail industry which returned -6.3% over the past year.
  • PETS underperformed the Market in United States of America which returned 0.8% over the past year.
Price Volatility
PETS
Industry
5yr Volatility vs Market

Value

 Is PetMed Express undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of PetMed Express to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for PetMed Express.

NasdaqGS:PETS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 11.3%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:PETS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Online Retail Unlevered Beta Simply Wall St/ S&P Global 1.66
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.662 (1 + (1- 21%) (0%))
1.444
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.44
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.444 * 5.96%)
11.34%

Discounted Cash Flow Calculation for NasdaqGS:PETS using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for PetMed Express is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqGS:PETS DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 11.34%)
2019 44.89 Analyst x2 40.32
2020 35.66 Analyst x3 28.77
2021 42.15 Analyst x3 30.54
2022 44.13 Est @ 4.71% 28.72
2023 45.95 Est @ 4.12% 26.86
2024 47.65 Est @ 3.7% 25.02
2025 49.27 Est @ 3.41% 23.24
2026 50.85 Est @ 3.21% 21.54
2027 52.41 Est @ 3.06% 19.94
2028 53.96 Est @ 2.96% 18.44
Present value of next 10 years cash flows $263.38
NasdaqGS:PETS DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $53.96 × (1 + 2.73%) ÷ (11.34% – 2.73%)
$644.20
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $644.20 ÷ (1 + 11.34%)10
$220.13
NasdaqGS:PETS Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $263.38 + $220.13
$483.52
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $483.52 / 19.97
$24.21
NasdaqGS:PETS Discount to Share Price
Calculation Result
Value per share (USD) From above. $24.21
Current discount Discount to share price of $17.60
= -1 x ($17.60 - $24.21) / $24.21
27.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price PetMed Express is available for.
Intrinsic value
27%
Share price is $17.6 vs Future cash flow value of $24.21
Current Discount Checks
For PetMed Express to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • PetMed Express's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • PetMed Express's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for PetMed Express's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are PetMed Express's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:PETS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $1.84
NasdaqGS:PETS Share Price ** NasdaqGS (2019-06-14) in USD $17.6
United States of America Online Retail Industry PE Ratio Median Figure of 29 Publicly-Listed Online Retail Companies 32.25x
United States of America Market PE Ratio Median Figure of 3,091 Publicly-Listed Companies 17.68x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of PetMed Express.

NasdaqGS:PETS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:PETS Share Price ÷ EPS (both in USD)

= 17.6 ÷ 1.84

9.54x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • PetMed Express is good value based on earnings compared to the US Online Retail industry average.
  • PetMed Express is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does PetMed Express's expected growth come at a high price?
Raw Data
NasdaqGS:PETS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 9.54x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
-5.7%per year
United States of America Online Retail Industry PEG Ratio Median Figure of 22 Publicly-Listed Online Retail Companies 2x
United States of America Market PEG Ratio Median Figure of 2,125 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

NasdaqGS:PETS PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 9.54x ÷ -5.7%

-1.67x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • PetMed Express earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on PetMed Express's assets?
Raw Data
NasdaqGS:PETS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $6.56
NasdaqGS:PETS Share Price * NasdaqGS (2019-06-14) in USD $17.6
United States of America Online Retail Industry PB Ratio Median Figure of 66 Publicly-Listed Online Retail Companies 2.87x
United States of America Market PB Ratio Median Figure of 5,244 Publicly-Listed Companies 1.79x
NasdaqGS:PETS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:PETS Share Price ÷ Book Value per Share (both in USD)

= 17.6 ÷ 6.56

2.68x

* Primary Listing of PetMed Express.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • PetMed Express is good value based on assets compared to the US Online Retail industry average.
X
Value checks
We assess PetMed Express's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Online Retail industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Online Retail industry average (and greater than 0)? (1 check)
  5. PetMed Express has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is PetMed Express expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-5.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is PetMed Express expected to grow at an attractive rate?
  • PetMed Express's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
  • PetMed Express's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
  • PetMed Express's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:PETS Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:PETS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts -5.7%
NasdaqGS:PETS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 2%
United States of America Online Retail Industry Earnings Growth Rate Market Cap Weighted Average 26.1%
United States of America Online Retail Industry Revenue Growth Rate Market Cap Weighted Average 16.7%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:PETS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:PETS Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-03-31 295 43 34 3
2020-03-31 287 39 32 3
NasdaqGS:PETS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 283 45 38
2018-12-31 286 34 41
2018-09-30 286 39 43
2018-06-30 282 46 41
2018-03-31 274 37 37
2017-12-31 270 51 35
2017-09-30 262 38 30
2017-06-30 256 48 27
2017-03-31 249 47 24
2016-12-31 242 30 22
2016-09-30 240 35 22
2016-06-30 236 23 21

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • PetMed Express's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • PetMed Express's revenue is expected to grow by 2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:PETS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from PetMed Express Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:PETS Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-03-31 1.77 1.98 1.50 3.00
2020-03-31 1.66 1.90 1.53 3.00
NasdaqGS:PETS Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 1.84
2018-12-31 2.02
2018-09-30 2.09
2018-06-30 1.99
2018-03-31 1.83
2017-12-31 1.70
2017-09-30 1.50
2017-06-30 1.31
2017-03-31 1.18
2016-12-31 1.08
2016-09-30 1.08
2016-06-30 1.06

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • PetMed Express is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess PetMed Express's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
PetMed Express has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has PetMed Express performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare PetMed Express's growth in the last year to its industry (Online Retail).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • PetMed Express has delivered over 20% year on year earnings growth in the past 5 years.
  • PetMed Express's 1-year earnings growth is less than its 5-year average (1.2% vs 20.9%)
  • PetMed Express's earnings growth has not exceeded the US Online Retail industry average in the past year (1.2% vs 1.3%).
Earnings and Revenue History
PetMed Express's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from PetMed Express Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:PETS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 283.42 37.74 46.92
2018-12-31 286.18 41.30 44.93
2018-09-30 286.22 42.58 45.46
2018-06-30 281.53 40.59 44.67
2018-03-31 273.80 37.28 43.55
2017-12-31 269.51 34.60 43.11
2017-09-30 262.27 30.36 41.70
2017-06-30 256.35 26.50 41.12
2017-03-31 249.18 23.82 40.46
2016-12-31 241.54 21.73 39.37
2016-09-30 239.60 21.80 39.80
2016-06-30 235.54 21.40 41.31
2016-03-31 234.68 20.57 43.14
2015-12-31 229.29 20.10 43.18
2015-09-30 227.64 20.01 43.54
2015-06-30 228.49 18.24 44.20
2015-03-31 229.40 17.45 46.23
2014-12-31 228.03 17.03 47.49
2014-09-30 228.84 16.77 47.79
2014-06-30 231.74 18.19 47.98
2014-03-31 233.39 17.97 48.53
2013-12-31 235.88 18.05 49.09
2013-09-30 235.40 18.08 49.22
2013-06-30 233.07 17.97 49.52
2013-03-31 227.83 17.17 49.03
2012-12-31 232.63 16.56 50.64
2012-09-30 233.55 15.88 51.59
2012-06-30 233.63 15.77 52.30

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • PetMed Express has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • PetMed Express used its assets more efficiently than the US Online Retail industry average last year based on Return on Assets.
  • PetMed Express's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess PetMed Express's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Online Retail industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
PetMed Express has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is PetMed Express's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up PetMed Express's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • PetMed Express is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • PetMed Express's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of PetMed Express's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • PetMed Express has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from PetMed Express Company Filings, last reported 2 months ago.

NasdaqGS:PETS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 134.68 0.00 100.53
2018-12-31 132.86 0.00 93.17
2018-09-30 129.84 0.00 87.13
2018-06-30 123.88 0.00 94.56
2018-03-31 115.73 0.00 77.94
2017-12-31 109.98 0.00 81.00
2017-09-30 104.32 0.00 68.44
2017-06-30 99.03 0.00 68.53
2017-03-31 93.37 0.00 58.73
2016-12-31 89.39 0.00 47.90
2016-09-30 87.96 0.00 51.90
2016-06-30 86.37 0.00 44.31
2016-03-31 83.20 0.00 37.64
2015-12-31 80.88 0.00 62.74
2015-09-30 79.24 0.00 57.78
2015-06-30 77.88 0.00 58.26
2015-03-31 75.44 0.00 51.20
2014-12-31 73.55 0.00 52.65
2014-09-30 71.85 0.00 50.16
2014-06-30 72.14 0.00 44.71
2014-03-31 70.22 0.00 33.84
2013-12-31 68.77 0.00 41.45
2013-09-30 67.16 0.00 51.40
2013-06-30 66.07 0.00 50.46
2013-03-31 64.01 0.00 33.65
2012-12-31 62.07 0.00 45.47
2012-09-30 80.11 0.00 62.47
2012-06-30 82.65 0.00 67.73
  • PetMed Express has no debt.
  • PetMed Express has not taken on any debt in the past 5 years.
  • PetMed Express has no debt, it does not need to be covered by operating cash flow.
  • PetMed Express has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess PetMed Express's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. PetMed Express has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is PetMed Express's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
6.14%
Current annual income from PetMed Express dividends. Estimated to be 6.34% next year.
If you bought $2,000 of PetMed Express shares you are expected to receive $123 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • PetMed Express's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.47%).
  • PetMed Express's dividend is above the markets top 25% of dividend payers in United States of America (3.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:PETS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
Global Online Retail Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2011 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:PETS Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-03-31 1.14 2.00
2020-03-31 1.09 2.00
NasdaqGS:PETS Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-05-28 1.080 6.130
2019-05-06 1.080 5.598
2018-10-22 1.080 4.603
2018-07-23 1.080 3.122
2018-01-22 1.000 2.450
2017-10-31 0.800 1.874
2017-10-23 0.800 2.160
2017-07-31 0.800 2.087
2017-07-24 0.800 1.648
2017-05-23 0.800 2.092
2017-05-08 0.800 2.371
2017-01-31 0.760 3.575
2017-01-23 0.760 3.581
2016-11-01 0.760 3.438
2016-10-24 0.760 3.843
2016-08-01 0.760 3.723
2016-07-25 0.760 3.666
2016-05-24 0.760 4.025
2016-05-10 0.760 4.036
2016-02-02 0.720 4.141
2016-01-25 0.720 4.065
2015-10-27 0.720 4.234
2015-10-19 0.720 4.313
2015-07-28 0.720 4.362
2015-07-20 0.720 4.237
2015-05-22 0.720 4.194
2015-05-04 0.720 4.404
2015-01-20 0.680 4.247
2014-10-20 0.680 4.976
2014-05-05 0.680 4.993
2014-01-30 0.680 5.133
2013-10-28 0.680 4.475
2013-07-26 0.680 4.252
2013-05-03 0.600 4.447
2013-01-28 0.600 4.566
2012-10-31 0.600 5.317
2012-07-30 0.600 5.947
2012-05-07 0.600 5.255
2012-01-30 0.600 4.839
2011-10-31 0.500 4.970
2011-08-01 0.500 5.137
2011-05-09 0.500 4.173
2011-01-31 0.500 3.342
2010-11-01 0.500 2.950
2010-08-02 0.500 3.041
2010-05-03 0.400 2.185
2010-02-02 0.400 1.898
2009-11-02 0.400 2.290
2009-08-03 0.400 2.208

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of PetMed Express's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.7x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.5x coverage).
X
Income/ dividend checks
We assess PetMed Express's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can PetMed Express afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. PetMed Express has a total score of 6/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of PetMed Express's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Menderes Akdag
COMPENSATION $1,221,485
AGE 57
TENURE AS CEO 18.3 years
CEO Bio

Mr. Menderes Akdag has been the Chief Executive Officer of PetMed Express, Inc. since March 16, 2001 and has been its President since August 2005. Mr. Akdag has a breadth of experience in the areas of direct response marketing, operations, and finance. Mr. Akdag has played a vital role in the continuing development and implementation of PetMed's strategic business plan, leading it into its expansion into online retail sales and pursuing nationwide recognition of its brand. Prior to joining PetMed Express Inc., from November 15, 2000 to March 31, 2001, Mr. Akdag served as the Chief Executive Officer of International Cosmetics Marketing Co. (d/b/a Beverly Sassoon & Co.). From May 1991 to August 2000, he was employed by Lens Express, Inc., a subsidiary of Summit Autonomous, Inc. He served as the President of Lens Express from May 1995 to August 2000, Chief Executive Officer from August 1992 to May 1996 and Chief Financial Officer from May 1991 to August 1992. Mr. Akdag served as Finance Manager for Beksa Steel Cord Manufacturing and Trading Inc. Mr. Akdag has been a Director of PetMed Express, Inc. since November 20, 2002. Mr. Akdag serves as a Director of Integrity Tracking, LLC. He served as a Member of the Board of Directors of Lens Express, Inc. from August 1992 to May 1996 and International Cosmetics Marketing Co. until December 18, 2000. Mr. Akdag served as a Member of the Board of Directors at Netel Inc. In 2009, Mr. Akdag was an Ernst & Young® Entrepreneur of the Year Florida Winner in the retail category as well as a national finalist. Recognized globally, the award honors the most outstanding entrepreneurs who inspire others with their vision, leadership, and achievement. Mr. Akdag holds a Bachelor of Science degree in Business Administration with a major in Finance from the University of Florida where he graduated with high honors.

CEO Compensation
  • Menderes's compensation has increased by more than 20% in the past year whilst earnings grew less than 20%.
  • Menderes's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Menderes Akdag

TITLE
CEO, President & Director
COMPENSATION
$1M
AGE
57
TENURE
18.3 yrs

Bruce Rosenbloom

TITLE
CFO & Treasurer
COMPENSATION
$1M
AGE
49
TENURE
18.1 yrs

Alison Berges

TITLE
Corporate Secretary & General Counsel
Board of Directors Tenure

Average tenure and age of the PetMed Express board of directors in years:

16.2
Average Tenure
71
Average Age
  • The average tenure for the PetMed Express board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Bob Schweitzer

TITLE
Chairman
COMPENSATION
$403K
AGE
72
TENURE
12.9 yrs

Menderes Akdag

TITLE
CEO, President & Director
COMPENSATION
$1M
AGE
57
TENURE
16.6 yrs

Ronald Korn

TITLE
Director
COMPENSATION
$403K
AGE
78
TENURE
16.6 yrs

Leslie C. Campbell

TITLE
Director
AGE
60
TENURE
0.9 yrs

Gian Fulgoni

TITLE
Director
COMPENSATION
$403K
AGE
70
TENURE
16.6 yrs

Frank Formica

TITLE
Independent Director
COMPENSATION
$403K
AGE
74
TENURE
15.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
14. Sep 18 Sell Robert Schweitzer Individual 13. Sep 18 13. Sep 18 -7,500 $37.00 $-277,500
X
Management checks
We assess PetMed Express's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. PetMed Express has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is PetMed Express, Inc. (NASDAQ:PETS) Trading At A 28% Discount?

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 10-year free cash flow (FCF) forecast 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Levered FCF ($, Millions) $44.89 $35.66 $42.15 $44.13 $45.95 $47.65 $49.27 $50.85 $52.41 $53.96 Growth Rate Estimate Source Analyst x2 Analyst x3 Analyst x3 Est @ 4.71% Est @ 4.12% Est @ 3.7% Est @ 3.41% Est @ 3.21% Est @ 3.06% Est @ 2.96% Present Value ($, Millions) Discounted @ 11.32% $40.33 $28.77 $30.55 $28.73 $26.87 $25.03 $23.25 $21.56 $19.96 $18.46 Present Value of 10-year Cash Flow (PVCF)= $263.51m "Est" = FCF growth rate estimated by Simply Wall St We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$54m × (1 + 2.7%) ÷ (11.3% – 2.7%) = US$645m Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$645m ÷ ( 1 + 11.3%)10 = $220.62m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $484.12m. … NasdaqGS:PETS Intrinsic value, June 11th 2019 Important assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows.

Simply Wall St -

PetMed Express, Inc. (NASDAQ:PETS): Did It Outperform The Industry?

(NASDAQ:PETS) announced its most recent earnings (31 March 2019), I did two things: looked at its past earnings track record, then look at what is happening in the industry. … However, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 21%, indicating the rate at which PETS is growing has slowed down. … I recommend you continue to research PetMed Express to get a more holistic view of the stock by looking at: Future Outlook: What are well-informed industry analysts predicting for PETS’s future growth?

Simply Wall St -

Here's Why I Think PetMed Express (NASDAQ:PETS) Is An Interesting Stock

In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like PetMed Express (NASDAQ:PETS). … I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. … PetMed Express maintained stable EBIT margins over the last year, all while growing revenue 6.2% to US$286m.

Simply Wall St -

A Closer Look At PetMed Express, Inc.'s (NASDAQ:PETS) Impressive ROE

Our data shows PetMed Express has a return on equity of 31% for the last year. … One way to conceptualize this, is that for each $1 of shareholders' equity it has, the company made $0.31 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Does PetMed Express, Inc. (NASDAQ:PETS) Have A Good P/E Ratio?

We'll show how you can use PetMed Express, Inc.'s (NASDAQ:PETS) P/E ratio to inform your assessment of the investment opportunity. … Based on the last twelve months, PetMed Express's P/E ratio is 11.59. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Simply Wall St -

Should You Like PetMed Express, Inc.’s (NASDAQ:PETS) High Return On Capital Employed?

Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … What is Return On Capital Employed (ROCE)? … Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Simply Wall St -

PetMed Express, Inc. (NASDAQ:PETS) Should Be In Your Dividend Portfolio, Here's Why

Over the past 10 years PetMed Express, Inc. … With a market cap of US$434m, PetMed Express pays out 51% of its earnings, leading to a 5.1% yield. … It has paid dividend every year without dramatically reducing payout in the past

Simply Wall St -

Should PetMed Express, Inc. (NASDAQ:PETS) Be Part Of Your Dividend Portfolio?

The company currently pays out a dividend yield of 5.0% to shareholders, making it a relatively attractive dividend stock. … Does PetMed Express tick all the boxes of a great dividend stock? … 5 checks you should do on a dividend stock

Simply Wall St -

Did PetMed Express's Share Price Deserve to Gain 65%?

(NASDAQ:PETS) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 11% in the last quarter. … During five years of share price growth, PetMed Express achieved compound earnings per share (EPS) growth of 19% per year. … The EPS growth is more impressive than the yearly share price gain of 10% over the same period.

Simply Wall St -

Should You Be Pleased About The CEO Pay At PetMed Express, Inc.'s (NASDAQ:PETS)

Menderes Akdag has been the CEO of PetMed Express, Inc. … First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Menderes Akdag's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Company Info

Description

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Details
Name: PetMed Express, Inc.
PETS
Exchange: NasdaqGS
Founded: 1996
$351,538,968
19,973,805
Website: http://www.1800petmeds.com
Address: PetMed Express, Inc.
420 South Congress Avenue,
Delray Beach,
Florida, 33445,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS PETS Common Stock Nasdaq Global Select US USD 16. Sep 1997
DB PQM Common Stock Deutsche Boerse AG DE EUR 16. Sep 1997
Number of employees
Current staff
Staff numbers
199
PetMed Express employees.
Industry
Internet and Direct Marketing Retail
Retail
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/15 23:42
End of day share price update: 2019/06/14 00:00
Last estimates confirmation: 2019/05/07
Last earnings filing: 2019/05/28
Last earnings reported: 2019/03/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.